Abstract:Background CD4 + memory T cells are an important component of the tumor microenvironment (TME) and affect tumor occurrence and progression. Nevertheless, there has been no systematic analysis of the effect of CD4 + memory T cells in gastric cancer (GC). Methods Three datasets obtained from microarray and the corresponding clinical data of GC patients were retrieved and downloaded from the Gene Expression Omnibus (GEO) database. We uploaded the normalize gene expression data with standard annotation to the CIBERSORT web portal for evaluating the proportion of immune cells in the GC samples. The WGCNA was performed to identify the modules the CD4 + memory T cell related module (CD4 + MTRM) which was most significantly associated with CD4 + memory T cell. Univariate Cox analysis was used to screen prognostic CD4 + memory T cell-related genes (CD4 + MTRGs) in CD4 + MTRM. LASSO analysis and multivariate Cox analysis were then performed to construct a prognostic gene signature whose effect was evaluated by Kaplan-Meier curves and receiver operating characteristic (ROC), Harrell’s concordance index (C-index), and decision curve analyses (DCA). A prognostic nomogram was finally established based on the CD4 + MTRGs. Result We observed that a high abundance of CD4 + memory T cells was associated with better survival in GC patients. CD4 + MTRM was used to stratify GC patients into three clusters by unsupervised clustering analysis and ten CD4 + MTRGs were identified. Overall survival, five immune checkpoint genes and 17 types of immunocytes were observed to be significantly different among the three clusters. A ten-CD4 + MTRG signature was constructed to predict GC patient prognosis. The ten-CD4 + MTRG signature could divide GC patients into high- and low-risk groups with distinct OS rates. Multivariate Cox analysis suggested that the ten-CD4 + MTRG signature was an independent risk factor in GC. A nomogram incorporating this signature and clinical variables was established, and the C-index was 0.73 (95% CI: 0.697–0.763). Calibration curves and DCA presented high credibility for the OS nomogram. Conclusion We identified three molecule subtypes, ten CD4 + MTRGs, and generated a prognostic nomogram that reliably predicts OS in GC. These findings have implications for precise prognosis prediction and individualized targeted therapy.

Molecular classification reveals the diverse genetic features and prognosis of gastric cancer: a multi-omics consensus ensemble clustering

Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering

Identification of Tumor Mutation Burden, Microsatellite Instability, and Somatic Copy Number Alteration Derived Nine Gene Signatures to Predict Clinical Outcomes in STAD.

The Combination of Exon Sequencing and Metabolomics to Establish a Molecular Typing System for Gastric Cancer

A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics

A transcriptomic study for identifying cardia- and non-cardia-specific gastric cancer prognostic factors using genetic algorithm-based methods

Identifying gastric cancer molecular subtypes by integrating DNA-based hierarchical classification strategy and clinical stratification

Classification of Gastric Cancers Based on Immunogenomic Profiling.

Hierarchical learning of gastric cancer molecular subtypes by integrating multi‐modal DNA‐level omics data and clinical stratification

Molecular Characterization and Clinical Relevance of Metabolic Signature Subtypes in Gastric Cancer

Abstract 5142: Proteome-wide Analysis Identifies Three Subgroups of Diffuse-Type Gastric Cancer

Molecular Subtypes and CD4+ Memory T Cell-Based Signature Associated With Clinical Outcomes in Gastric Cancer

Identification of angiogenesis-related subtypes and risk models for predicting the prognosis of gastric cancer patients

[Research Progress in Molecular Classification of Gastric Cancer].

Unsupervised Hierarchical Clustering Identifies Immune Gene Subtypes in Gastric Cancer

Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating with the Response to Immunotherapy in Patients with Gastric Cancer

Molecular and cellular heterogeneity of gastric cancer explained by methylation-driven key regulators

Development of a Streamlined NGS-based TCGA Classification Scheme for Gastric Cancer and Its Implications for Personalized Therapy

Protein Expression-Based Classification Of Gastric Cancer By Immunohistochemistry Of Tissue Microarray

Prognostic effect of immunohistochemically determined molecular subtypes in gastric cancer

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes